PARAPLATIN Side Effects

7014795-4 | Interstitial Lung Disease, Pneumothorax, Respiratory Failure
on Sep 15, 2010 Male patient from JAPAN , 64 years of age, was diagnosed with lung neoplasm malignant, pneumothorax and was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pneumothorax, respiratory failure. Paraplatin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), PICIBANIL (Given On 28aug06(5ke,1day);also On 30aug06,5sep06,11sep06 And 21sep06(10ke,4days)) (View Picibanil Review and Picibanil Label ), GASTER D (View Gaster D Review and Gaster D Label ), EURODIN (View Eurodin Review and Eurodin Label ), MAGLAX (View Maglax Review and Maglax Label ), PREDONINE (View Predonine Review and Predonine Label ), PURSENNID (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

7014789-9 | Pneumothorax
Patient was taking Paraplatin (View Usage). Patient had the following side effects: pneumothorax on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with lung neoplasm malignant and. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), MAGLAX (View Maglax Review and Maglax Label ), ZOFRAN (View Zofran Review and Zofran Label ), CONTOMIN (View Contomin Review and Contomin Label ). Patient was hospitalized.

7014788-7 | Neuropathy Peripheral, Pneumothorax
Adverse event was reported on Sep 15, 2010 by a Male patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: JAPAN , 56 years of age, After Paraplatin was administered, patient had the following side effects: neuropathy peripheral, pneumothorax. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), SEREVENT (View Serevent Review and Serevent Label ). Patient was hospitalized.

7014780-2 | Bone Marrow Failure, Pneumothorax
on Sep 15, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with lung neoplasm malignant and was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, pneumothorax. Paraplatin dosage: 450mg,1/1 Month. Iv Drip, 04jul07-12may08,8days.600mg,01oct08-unk.4 Days. During the same period patient was treated with VEPESID (4 Days) (View Vepesid Review and Vepesid Label ), AMRUBICIN HCL (View Amrubicin Hcl Review and Amrubicin Hcl Label ), ARTIST (View Artist Review and Artist Label ), BLOPRESS (View Blopress Review and Blopress Label ), OMEPRAL (View Omepral Review and Omepral Label ), AVISHOT (View Avishot Review and Avishot Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ). Patient was hospitalized.


7014779-6 | Pneumothorax
on Sep 15, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with lung neoplasm malignant and was treated with Paraplatin (View Usage). Patient had the following side effects: pneumothorax. Paraplatin dosage: Till 12dec2008. During the same period patient was treated with TAXOL (Till 12dec2008) (View Taxol Review and Taxol Label ).

7012479-X | Pneumothorax
Patient was taking Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: pneumothorax on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with lung neoplasm malignant and. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), MAGLAX (View Maglax Review and Maglax Label ), ZOFRAN (View Zofran Review and Zofran Label ), CONTOMIN (View Contomin Review and Contomin Label ). Patient was hospitalized.

7004956-2 | Hypercapnia, Tracheal Disorder
Adverse event was reported on Sep 16, 2010 by a Female patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: hypercapnia, tracheal disorder. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), AVASTIN (Inj) (View Avastin Review and Avastin Label ).

6981408-7 | Arthralgia, Gait Disturbance, Haemorrhage, Neuropathy Peripheral
on Sep 10, 2010 Female patient from SWEDEN , 62 years of age, was treated with Paraplatin (View Usage). Patient had the following side effects: arthralgia, gait disturbance, haemorrhage, neuropathy peripheral. Paraplatin dosage: Last Dose In Jun10. During the same period patient was treated with PAXENE (2nd Treatment On 19apr10(300mg),3rd On 10may10(300mg), Dose Reduced-4th On 01jun10(270mg)) (View Paxene Review and Paxene Label ), OMEPRAZOLE (At Night) (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (At Night) (View Acetaminophen Review and Acetaminophen Label ), ZOLPIDEM (At Night) (View Zolpidem Review and Zolpidem Label ), PROPIOMAZINE (At Night) (View Propiomazine Review and Propiomazine Label ).

6971247-5 | Angiosclerosis
on Sep 02, 2010 Male patient from JAPAN , 66 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: angiosclerosis. Paraplatin dosage: 1df=6auc Dose: 585mg/d. During the same period patient was treated with TAXOL (80mg/m2/wk) (View Taxol Review and Taxol Label ), RESTAMIN (View Restamin Review and Restamin Label ), DECADRON (Injection) (View Decadron Review and Decadron Label ), FAMOTIDINE (Injection) (View Famotidine Review and Famotidine Label ), KYTRIL (View Kytril Review and Kytril Label ).

6940339-9 | Histiocytosis Haematophagic, Leukaemia
Patient was taking Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic, leukaemia on Aug 19, 2010 from JAPAN Additional patient health information: Female patient , 44 years of age, was diagnosed with sarcoma and. Paraplatin dosage: 1 D.f:400mg/body. During the same period patient was treated with VEPESID (1 D.f:100mg/body) (View Vepesid Review and Vepesid Label ), DOXORUBICIN HCL (1 D.f:80mg/body Inj) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PIRARUBICIN (1 D.f:50mg/body Inj) (View Pirarubicin Review and Pirarubicin Label ). Patient was hospitalized.

6883803-3 | Angiosclerosis
Adverse event was reported on Jul 26, 2010 by a Male patient taking Paraplatin (View Usage) (Dosage: 1df=6auc) was diagnosed with non-small cell lung cancer and. Location: JAPAN , 66 years of age, Patient had the following side effects: angiosclerosis. During the same period patient was treated with TAXOL (80mg/m2/wk) (View Taxol Review and Taxol Label ).

6855215-X | Acute Myeloid Leukaemia, Bone Marrow Failure, Oesophagitis
on Jul 13, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with oesophageal carcinoma and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: acute myeloid leukaemia, bone marrow failure, oesophagitis. Paraplatin dosage: . During the same period patient was treated with LASTET (View Lastet Review and Lastet Label ).

6836461-8 | Acute Myeloid Leukaemia, Bone Marrow Failure, Oesophagitis
on Jul 01, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with oesophageal carcinoma and was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, bone marrow failure, oesophagitis. Paraplatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6827131-0 | Diarrhoea, Full Blood Count Decreased, Platelet Count Decreased, Pleural Effusion, Vomiting
Patient was taking Paraplatin (View Usage). Patient had the following side effects: diarrhoea, full blood count decreased, platelet count decreased, pleural effusion, vomiting on Jul 01, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, . Paraplatin dosage: Cyc 2:240mg,cyc 3:240mg,cyc 5:200mg,cyc 6:165mg(auc5). During the same period patient was treated with IRINOTECAN HCL (Cyc 2:90mg(60mg/m2),cyc 3:70mg,cyc 5:70mg,cyc 6:70mg(48mg/m2).) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), AMRUBICIN HCL (Cycle 4) (View Amrubicin Hcl Review and Amrubicin Hcl Label ).

6816437-7 | Cardio-respiratory Arrest
Adverse event was reported on Jul 01, 2010 by a Female patient taking Paraplatin (View Usage) (Dosage: No Of Infusion=8) was diagnosed with uterine cancer (What is uterine cancer?) and. Location: JAPAN , 51 years of age, weighting 138.9 lb, After Paraplatin was administered, patient had the following side effects: cardio-respiratory arrest. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ).

6784516-9 | Cardio-respiratory Arrest
on Jun 17, 2010 Female patient from JAPAN , 51 years of age, weighting 138.9 lb, was diagnosed with uterine cancer (What is uterine cancer?) and was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest. Paraplatin dosage: No Of Infusion=8. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ).

6784515-7 | Renal Impairment
on Jun 17, 2010 Male patient from JAPAN , 64 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Paraplatin (View Usage). Patient had the following side effects: renal impairment. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), AVASTIN (View Avastin Review and Avastin Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), SOL MELCORT (View Sol Melcort Review and Sol Melcort Label ), LASIX (View Lasix Review and Lasix Label ).

6770894-3 | Renal Impairment
Patient was taking Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: renal impairment on Jun 10, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), AVASTIN (View Avastin Review and Avastin Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), SOL MELCORT (View Sol Melcort Review and Sol Melcort Label ), LASIX (View Lasix Review and Lasix Label ).

6770893-1 | Diarrhoea, Full Blood Count Decreased, Platelet Count Decreased, Pleural Effusion, Vomiting
Adverse event was reported on Jun 08, 2010 by a Male patient taking Paraplatin (View Usage) (Dosage: Cyc 2:240mg,cyc 3:240mg,cyc 5:200mg,cyc 6:165mg(auc5)) . Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, full blood count decreased, platelet count decreased, pleural effusion, vomiting. During the same period patient was treated with IRINOTECAN HCL (Cyc 2:90mg(60mg/m2),cyc 3:70mg,cyc 5:70mg,cyc 6:70mg(48mg/m2).) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), AMRUBICIN HCL (Cycle 4) (View Amrubicin Hcl Review and Amrubicin Hcl Label ).

6759567-0 | Renal Impairment
on Jun 03, 2010 Male patient from JAPAN , 64 years of age, weighting 114.6 lb, was treated with Paraplatin (View Usage). Patient had the following side effects: renal impairment. Paraplatin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), AVASTIN (View Avastin Review and Avastin Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), SOL MELCORT (View Sol Melcort Review and Sol Melcort Label ), LASIX (View Lasix Review and Lasix Label ).

6755924-7 | Diarrhoea, Full Blood Count Decreased, Platelet Count Decreased, Pleural Effusion, Vomiting
on May 25, 2010 Male patient from JAPAN , 69 years of age, was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: diarrhoea, full blood count decreased, platelet count decreased, pleural effusion, vomiting. Paraplatin dosage: Cyc 2:240mg,cyc 3:240mg,cyc 5:200mg,cyc 6:165mg(auc5). During the same period patient was treated with IRINOTECAN HCL (Cyc 2:90mg(60mg/m2),cyc 3:70mg,cyc 5:70mg,cyc 6:70mg(48mg/m2).) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), AMRUBICIN HCL (Cycle 4) (View Amrubicin Hcl Review and Amrubicin Hcl Label ).

6755901-6 | Bone Marrow Failure, Infection
Patient was taking Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, infection (What is infection?) on May 25, 2010 from JAPAN Additional patient health information: Male patient , 31 years of age, was diagnosed with germ cell cancer and. Paraplatin dosage: . During the same period patient was treated with IFOMIDE (View Ifomide Review and Ifomide Label ), RANDA (View Randa Review and Randa Label ), BLEO (View Bleo Review and Bleo Label ), LASTET INJ (Inj) (View Lastet Inj Review and Lastet Inj Label ).

6754353-X | Myelodysplastic Syndrome
Adverse event was reported on May 27, 2010 by a Male patient taking Paraplatin (View Usage) (Dosage: 4 Courses) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 70 years of age, Patient had the following side effects: myelodysplastic syndrome. During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ).

6753692-6 | Bone Marrow Failure, Infection
on May 25, 2010 Male patient from JAPAN , 25 years of age, was diagnosed with germ cell cancer and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: bone marrow failure, infection (What is infection?). Paraplatin dosage: . During the same period patient was treated with IFOMIDE (Inj) (View Ifomide Review and Ifomide Label ), RANDA (View Randa Review and Randa Label ), LASTET INJ (View Lastet Inj Review and Lastet Inj Label ), BLEO (View Bleo Review and Bleo Label ).

6742344-4 | Ewing's Sarcoma
on May 18, 2010 Female patient from JAPAN , child 11 years of age, was diagnosed with bone sarcoma and was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: ewing's sarcoma. Paraplatin dosage: 1 Df= 1 G/m2. During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), IFOSFAMIDE (1 Df= 29 G/m2) (View Ifosfamide Review and Ifosfamide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6736506-X | Fatigue, Mucosal Inflammation, Vasospasm
Patient was taking Paraplatin (View Usage). Patient had the following side effects: fatigue, mucosal inflammation, vasospasm on May 19, 2010 from SWITZERLAND Additional patient health information: Male patient , 50 years of age, was diagnosed with tonsil cancer and. Paraplatin dosage: . During the same period patient was treated with ERBITUX (View Erbitux Review and Erbitux Label ), CISPLATIN (For 2 Cycles, Cisplatin Had Been Replaced With Carboplatin) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6711272-2 | Malignant Neoplasm Progression, Pneumatosis Intestinalis, Pneumonia
Adverse event was reported on Apr 30, 2010 by a Male patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant, diabetes mellitus and. Location: JAPAN , 69 years of age, weighting 132.3 lb, After Paraplatin was administered, patient had the following side effects: malignant neoplasm progression, pneumatosis intestinalis, pneumonia (What is pneumonia?). During the same period patient was treated with CAMPTOSAR (View Camptosar Review and Camptosar Label ), LASTET (View Lastet Review and Lastet Label ), AMRUBICIN HCL (View Amrubicin Hcl Review and Amrubicin Hcl Label ), EUGLUCON (View Euglucon Review and Euglucon Label ), BASEN (Basen Od) (View Basen Review and Basen Label ). Patient was hospitalized.

6698243-X | Pneumatosis Intestinalis
on Apr 20, 2010 Male patient from JAPAN , 69 years of age, was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumatosis intestinalis. Paraplatin dosage: . During the same period patient was treated with IRINOTECAN HCL (Injection) (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6675778-7 | Abscess, Diverticular Perforation, Malignant Neoplasm Progression
on Mar 30, 2010 Male patient from JAPAN , 65 years of age, was diagnosed with cancer pain and was treated with Paraplatin (View Usage). Patient had the following side effects: abscess (What is abscess?), diverticular perforation, malignant neoplasm progression. Paraplatin dosage: . During the same period patient was treated with LASTET (View Lastet Review and Lastet Label ), OXYCODONE HCL (Oxycodone Hcl Hydrate) (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6653725-1 | Scleroderma
Patient was taking Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: scleroderma (What is scleroderma?) on Mar 16, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 116.8 lb, . Paraplatin dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ).

6577056-3 | Nephropathy Toxic
Adverse event was reported on Feb 04, 2010 by a Female patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with peritoneal mesothelioma malignant and. Location: JAPAN , 81 years of age, Patient experienced the following unwanted or unexpected effects: nephropathy toxic. During the same period patient was treated with PEMETREXED DISODIUM (Injection) (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ).

6520591-4 | Amoebic Dysentery, Enterovesical Fistula, Liver Abscess
on Dec 16, 2009 Male patient from JAPAN , 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Paraplatin (View Usage). Patient had the following side effects: amoebic dysentery, enterovesical fistula, liver abscess. Paraplatin dosage: . During the same period patient was treated with DOCETAXEL (Formulation:inj) (View Docetaxel Review and Docetaxel Label ).

6449232-1 | Polymyositis
on Nov 12, 2009 Male patient from JAPAN , 55 years of age, weighting 163.1 lb, was diagnosed with thymoma, myasthenia gravis, benign prostatic hyperplasia, insomnia and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: polymyositis. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ), PREDNISOLONE (Form:tab 30mg Every Other Day) (View Prednisolone Review and Prednisolone Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (Tab 1 Df = 4tablet 4tablet/day Twice Weekly) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), AMBENONIUM CHLORIDE (Tab 10x2mg/day:feb95) (View Ambenonium Chloride Review and Ambenonium Chloride Label ), HERBAL MIXTURE (1 Df = 3 Tabs 3x3 Tabs/day Form:tabs) (View Herbal Mixture Review and Herbal Mixture Label ), TACROLIMUS (Tacrolimus Hydrate Also Taken Jan05) (View Tacrolimus Review and Tacrolimus Label ), BROTIZOLAM (Tab) (View Brotizolam Review and Brotizolam Label ).

6427074-0 | Polymyositis
Patient was taking Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: polymyositis on Oct 26, 2009 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with thymoma and. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ).

6359878-7 | Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Sep 14, 2009 by a Female patient taking Paraplatin (View Usage) (Dosage: Another Administration: Feb05.) was diagnosed with gingival cancer and. Location: JAPAN , 70 years of age, Patient had the following side effects: inappropriate antidiuretic hormone secretion. During the same period patient was treated with DOCETAXEL (Another Adm:feb05.) (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (Anotheradm:feb05.) (View Fluorouracil Review and Fluorouracil Label ), ELECTROLYTES (View Electrolytes Review and Electrolytes Label ).

6356146-4 | Papilloedema, Retinal Haemorrhage, Vitreous Haemorrhage
on Sep 10, 2009 Male patient from SWEDEN , 65 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: papilloedema, retinal haemorrhage, vitreous haemorrhage. Paraplatin dosage: Concentrate For Solution For Infusion;given 5 Times In 3 Months. During the same period patient was treated with ALIMTA (Given 5 Times In 3 Months;powder For Concentrate For Solution For Inf) (View Alimta Review and Alimta Label ), OXYNORM (Capsule,hard 5mg) (View Oxynorm Review and Oxynorm Label ), PAMOL (Film Coated Tablet 500mg (nycomed Ab) (paracetamol).) (View Pamol Review and Pamol Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), LACTULOSE (Laktulos Alternova Syrup 667 Mg/ml) (View Lactulose Review and Lactulose Label ), BETAPRED (Tablet 0.5mg (defiante Farmaceutica S.a.) (betamethasone Sodium Phosphate, Betamethasone).) (View Betapred Review and Betapred Label ), OXASCAND (Tablet 5mg (teva Sweden Ab) (oxazepam)) (View Oxascand Review and Oxascand Label ), NAVOBAN (Capsule,hard 5mg (novartis Sverige Ab) (tropisetron, Tropisetron Hydrochloride).) (View Navoban Review and Navoban Label ).

6347256-6 | Interstitial Lung Disease
on Sep 04, 2009 Male patient from JAPAN , 72 years of age, was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ).

6293546-5 | Deep Vein Thrombosis
Patient was taking Paraplatin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Jul 22, 2009 from JAPAN Additional patient health information: Female patient , 49 years of age, was diagnosed with lung adenocarcinoma stage iv and. Paraplatin dosage: . During the same period patient was treated with DOCETAXEL (Form = Inj) (View Docetaxel Review and Docetaxel Label ).

6293065-6 | Deep Vein Thrombosis, Interstitial Lung Disease
Adverse event was reported on Jul 22, 2009 by a Male patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 64 years of age, After Paraplatin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), interstitial lung disease. During the same period patient was treated with DOCETAXEL (Form = Inj) (View Docetaxel Review and Docetaxel Label ), IRINOTECAN HCL (Irinotecan Hcl Hydrate Form = Inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), GEMCITABINE HCL (Form = Inj) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ).

6293063-2 | Deep Vein Thrombosis
on Jul 22, 2009 Male patient from JAPAN , 47 years of age, was diagnosed with lung adenocarcinoma and was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Paraplatin dosage: . During the same period patient was treated with DOCETAXEL (Form = Inj) (View Docetaxel Review and Docetaxel Label ), IRINOTECAN HCL (Form = Inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), GEMCITABINE HCL (Form = Inj) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ).

6293055-3 | Pulmonary Embolism
on Jul 22, 2009 Male patient from JAPAN , 77 years of age, was treated with Paraplatin (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Paraplatin dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ), IRINOTECAN HCL (Form = Inj) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), AMRUBICIN HCL (Form = Inj) (View Amrubicin Hcl Review and Amrubicin Hcl Label ), ADRIAMYCIN RDF (Form = Inj) (View Adriamycin Rdf Review and Adriamycin Rdf Label ), NIMUSTINE HCL (Form = Inj) (View Nimustine Hcl Review and Nimustine Hcl Label ), VINDESINE SULFATE (Form = Inj) (View Vindesine Sulfate Review and Vindesine Sulfate Label ), DOCETAXEL (Form = Inj) (View Docetaxel Review and Docetaxel Label ).

6293054-1 | Pulmonary Embolism
Patient was taking Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Jul 22, 2009 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with lung adenocarcinoma and. Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), GEMCITABINE (Form = Inj) (View Gemcitabine Review and Gemcitabine Label ).

6293051-6 | Pulmonary Embolism
Adverse event was reported on Jul 22, 2009 by a Male patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), DOCETAXEL (Form = Inj) (View Docetaxel Review and Docetaxel Label ), VINORELBINE (Vinorelbine Ditartrate Form = Inj) (View Vinorelbine Review and Vinorelbine Label ), GEMCITABINE (Form = Inj) (View Gemcitabine Review and Gemcitabine Label ), TEGAFUR + GIMERACIL + OTERACIL POTASSIUM (Form = Cap) (View Tegafur + Gimeracil + Oteracil Potassium Review and Tegafur + Gimeracil + Oteracil Potassium Label ).

6289426-1 | Encephalopathy
on Jul 28, 2009 Female patient from JAPAN , 50 years of age, weighting 88.18 lb, was diagnosed with neuroendocrine carcinoma, prophylaxis, constipation (What is constipation?), deep vein thrombosis (What is deep vein thrombosis?), abdominal distension, anaemia and was treated with Paraplatin (View Usage). Patient had the following side effects: encephalopathy. Paraplatin dosage: . During the same period patient was treated with LASTET (Form-inj.) (View Lastet Review and Lastet Label ), POLAPREZINC (Form = Gra) (View Polaprezinc Review and Polaprezinc Label ), SENNOSIDE A+B (Form = Gra) (View Sennoside A+b Review and Sennoside A+b Label ), WARFARIN POTASSIUM (Form = Tab) (View Warfarin Potassium Review and Warfarin Potassium Label ), DAI KENCHU TO (Form = Gra) (View Dai-kenchu-to Review and Dai-kenchu-to Label ), FERROUS CITRATE (Form = Tab) (View Ferrous Citrate Review and Ferrous Citrate Label ). Patient was hospitalized.

6275403-3 | Encephalopathy
on Jul 14, 2009 Female patient from JAPAN , 50 years of age, weighting 88.18 lb, was diagnosed with neuroendocrine carcinoma, prophylaxis, constipation (What is constipation?), deep vein thrombosis (What is deep vein thrombosis?), abdominal distension, anaemia and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: encephalopathy. Paraplatin dosage: . During the same period patient was treated with LASTET (Form-inj.) (View Lastet Review and Lastet Label ), POLAPREZINC (Form = Gra) (View Polaprezinc Review and Polaprezinc Label ), SENNOSIDE A+B (Form = Gra) (View Sennoside A+b Review and Sennoside A+b Label ), WARFARIN POTASSIUM (Form = Tab) (View Warfarin Potassium Review and Warfarin Potassium Label ), DAI KENCHU TO (Form = Gra) (View Dai-kenchu-to Review and Dai-kenchu-to Label ), FERROUS CITRATE (Form = Tab) (View Ferrous Citrate Review and Ferrous Citrate Label ). Patient was hospitalized.

6270492-4 | Interstitial Lung Disease
Patient was taking Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Jul 13, 2009 from JAPAN Additional patient health information: Male patient , 72 years of age, . Paraplatin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ).

6249714-1 | Encephalitis Herpes
Adverse event was reported on Jun 22, 2009 by a Male patient taking Paraplatin (View Usage) (Dosage: ) was diagnosed with brain cancer metastatic and. Location: JAPAN , 71 years of age, Patient had the following side effects: encephalitis herpes. During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ).

6242205-3 | Interstitial Lung Disease
on Jun 15, 2009 Male patient from JAPAN , 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Paraplatin (View Usage). After Paraplatin was administered, patient had the following side effects: interstitial lung disease. Paraplatin dosage: . During the same period patient was treated with RANDA (View Randa Review and Randa Label ).

6228934-6 | Dehydration, Fatigue, Malignant Neoplasm Progression, Neutropenia
on Jun 11, 2009 Female patient from UNITED STATES , 47 years of age, weighting 176.4 lb, was treated with Paraplatin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, fatigue, malignant neoplasm progression, neutropenia. Paraplatin dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ). Patient was hospitalized.

6215186-6 | Dehydration, Fatigue, Malignant Neoplasm Progression, Neutropenia
Patient was taking Paraplatin (View Usage). Patient had the following side effects: dehydration, fatigue, malignant neoplasm progression, neutropenia on Jun 02, 2009 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 176.4 lb, . Paraplatin dosage: . During the same period patient was treated with VEPESID (View Vepesid Review and Vepesid Label ). Patient was hospitalized.